Onconova Therapeutics Announces Topline Results from the Pivotal Phase 3 INSPIRE Trial

NEXT STORY
ImmunoGenesis Awarded $15.5 M Grant from Cancer Prevention and Research Institute of Texas (CPRIT)
PREV STORY
Global Point-of-Care Data Management Software Market 2020-2025 – Hospitals/Critical Care Units Segment Forecast to Hold a Significant Market Share
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Dupixent® (dupilumab) pivotal trial meets all primary and secondary endpoints becoming first biologic medicine to significantly reduce signs and symptoms of moderate-to-severe atopic dermatitis in children as young as 6 months

author_avatar
NASDAQ Market News

Inivata Receives Medicare Final Coverage Decision for InVisionFirstTM-Lung Liquid Biopsy Test in Advanced Non-Small Cell Lung Cancer

author_avatar
NASDAQ Market News

BeyondSpring Announces Initiation of Phase 3 Clinical Development for Plinabulin for Prevention of Chemotherapy-Induced Neutropenia

NEW YORK, March 19, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global, clinical-stage ...

author_avatar
NASDAQ Market News